Provides discovery of regenerative cell-based therapeutics to treat intractable neurological disease.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Neurona Therapeutics is a pre-clinical stage biotechnology company focused on the discovery of regenerative cell-based therapeutics to treat intractable neurological disease.
Neurona Therapeutics Funding
Sign up to gain insights into Neurona Therapeutics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series F | Apr 03, 2025 | 102M | ||
| Series E | Feb 13, 2024 | 120M | ||
| Series D | Jun 22, 2021 | 42M | ||
| Series B | Feb 08, 2018 | 10M | ||
| Series A | Dec 28, 2016 | 21M | ||
| Series A | Dec 09, 2014 | 8M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Neurona Therapeutics Management Team
Investors
Fidelity
Soleus Capital Management
Column Group
Cormorant Asset Management
UCB
Willett Advisors
Lyfe Capital
SymBiosis
Sphera Funds Management
UC Investments (UCOP)
YK Bioventures
Ironfire Capital
Viking Global Investors
Spur Capital Partners
Schroders Capital
Ysios Capital Partners
Berkeley Frontier Fund
Topspin Partners
Euclidean Capital
Alexandria Venture Investments
Neurona Therapeutics Valuations & Financials
View real-time NPM data on Neurona Therapeutics stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Neurona Therapeutics
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Virta Health
Health Care
Online specialty medical clinic focused on reversing type 2 diabetes.
Color Genomics
Health Care
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
Benchling
Health Care
Cloud based platform for research and development in biotechnology.
Lyra
Health Care
Digital health startup using technology to connect companies and employees to mental health providers.
Cityblock Health
Health Care
Tech-driven care provider for communities with complex needs.
FAQ
We have answers
Neurona Therapeutics stock does not trade on public stock exchanges. Neurona Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Neurona Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Neurona Therapeutics Stock does not trade on public stock exchanges. In order to sell Neurona Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Neurona Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Neurona Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Neurona Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Neurona Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Neurona Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Neurona Therapeutics is a private company and has not had an IPO. There is currently no Neurona Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Neurona Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
